InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Campbell Bradley L, Chief Operating Officer. Director active across 1 companies, notably Amicus Therapeutics, INC.. Cumulatively, 23 filings have been recorded. The latest transaction was disclosed on 21 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations23 total
€54,99816,410 shares@ €3.35150.0012% mcap5.0% of flow
Common Stock
SEC:0001209191-22-038764:0·
104,603 shares
Common Stock
SEC:0001209191-22-023907:0·
€34,79310,940 shares@ €3.18030.0008% mcap3.2% of flow
Common Stock
SEC:0001209191-22-020611:0·
63,317 shares
Common Stock
SEC:0001209191-22-003816·
63,317 shares
Common Stock
SEC:0001209191-22-003816:0·
€179,46617,597 shares@ €10.19870.0039% mcap37.6% of flow
Common Stock
SEC:0001209191-22-001198·
€179,46617,597 shares@ €10.19870.0039% mcap16.3% of flow
Common Stock
SEC:0001209191-22-001198:0·
€11,6413,000 shares@ €3.88040.0003% mcap2.4% of flow
Common Stock
SEC:0001209191-21-071071·
€11,6413,000 shares@ €3.88040.0003% mcap1.1% of flow
Common Stock
SEC:0001209191-21-071071:0·
€40,64810,515 shares@ €3.86570.0009% mcap8.5% of flow
Common Stock
SEC:0001209191-21-067715·
€40,64810,515 shares@ €3.86570.0009% mcap3.7% of flow
Common Stock
SEC:0001209191-21-067715:0·
€39,85210,515 shares@ €3.790.0009% mcap8.4% of flow
Common Stock
SEC:0001209191-21-062793·
€39,85210,515 shares@ €3.790.0009% mcap3.6% of flow
Common Stock
SEC:0001209191-21-062793:0·
€39,79110,515 shares@ €3.78420.0009% mcap8.3% of flow
Common Stock
SEC:0001209191-21-059149·
€39,79110,515 shares@ €3.78420.0009% mcap3.6% of flow
Common Stock
SEC:0001209191-21-059149:0·
€38,89510,515 shares@ €3.6990.0009% mcap8.2% of flow
Common Stock
SEC:0001209191-21-055061·
€38,89510,515 shares@ €3.6990.0009% mcap3.5% of flow
Common Stock
SEC:0001209191-21-055061:0·
€77,81821,028 shares@ €3.70070.0017% mcap16.3% of flow
Common Stock
SEC:0001209191-21-050502·
€77,81821,028 shares@ €3.70070.0017% mcap7.1% of flow
Common Stock
SEC:0001209191-21-050502:0·
€48,97524,375 shares@ €2.00920.0011% mcap4.5% of flow
Common Stock
SEC:0001209191-21-039296·
€48,97524,375 shares@ €2.00920.0011% mcap4.5% of flow
Common Stock
SEC:0001209191-21-039296:0·
10,514 shares
Common Stock
SEC:0001209191-21-030437·
€56,22610,514 shares@ €5.34770.0012% mcap5.1% of flow
Common Stock
SEC:0001209191-21-030437:0·
23 of 23 declarations
About Campbell Bradley L
Campbell Bradley L is the Chief Operating Officer at AMICUS THERAPEUTICS, INC.
